Latest filing published 08 May 2015 for HYPERION THERAPEUTICS INC, €4.0M.
No signal scores available.
Bruce Frederick Scharschmidt is a declared insider of Hyperion Therapeutics Inc, with filings sourced from SEC (Form 4). We count 28 filings; the first trade dates from 31 October 2012 and the latest from 7 May 2015.
No open-market purchase appears, only 3 sales worth €799k. Besides market trades, the filings include 3 share grants and 18 option exercises. So far in 2015, the count stands at no purchases and 2 sales.
On 8 May 2015 came the latest disclosure, a transaction for €285k in Hyperion Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations